Technical Analysis for VNRX - VolitionRX Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 0.80 | -1.11% | -0.01 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 200 DMA | Bullish | -1.11% | |
| Crossed Above 50 DMA | Bullish | -1.11% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | -1.11% | |
| Pocket Pivot | Bullish Swing Setup | -1.11% | |
| Wide Bands | Range Expansion | -1.11% | |
| Above Upper BB | Strength | -1.11% | |
| Gapped Up | Strength | -1.11% | |
| Upper Bollinger Band Touch | Strength | -1.11% | |
| 50 DMA Resistance | Bearish | 19.55% | |
| 20 DMA Support | Bullish | 19.55% |
| Alert | Time |
|---|---|
| Expansion Pivot Buy Entry | 34 minutes ago |
| Rose Above Previous Day's High | 34 minutes ago |
| Up 3% | 34 minutes ago |
| Up 2% | 34 minutes ago |
| Up 1% | 34 minutes ago |
Get a Trading Sidekick!
- Earnings date: 11/12/2024
VolitionRX Limited Description
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Disease Molecular Biology Genomics Diagnostic Products Blood Test Epigenetics Endometriosis Cancer Detection Nucleotides
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.23 |
| 52 Week Low | 0.4301 |
| Average Volume | 124,157 |
| 200-Day Moving Average | 0.74 |
| 50-Day Moving Average | 0.68 |
| 20-Day Moving Average | 0.67 |
| 10-Day Moving Average | 0.71 |
| Average True Range | 0.07 |
| RSI (14) | 63.77 |
| ADX | 18.0 |
| +DI | 26.63 |
| -DI | 12.78 |
| Chandelier Exit (Long, 3 ATRs) | 0.60 |
| Chandelier Exit (Short, 3 ATRs) | 0.77 |
| Upper Bollinger Bands | 0.80 |
| Lower Bollinger Band | 0.53 |
| Percent B (%b) | 1.04 |
| BandWidth | 39.75 |
| MACD Line | 0.01 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.011 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.01 | ||||
| Resistance 3 (R3) | 0.99 | 0.90 | 0.97 | ||
| Resistance 2 (R2) | 0.90 | 0.85 | 0.91 | 0.96 | |
| Resistance 1 (R1) | 0.86 | 0.82 | 0.88 | 0.88 | 0.95 |
| Pivot Point | 0.77 | 0.77 | 0.79 | 0.78 | 0.77 |
| Support 1 (S1) | 0.73 | 0.72 | 0.75 | 0.75 | 0.67 |
| Support 2 (S2) | 0.64 | 0.69 | 0.65 | 0.66 | |
| Support 3 (S3) | 0.60 | 0.64 | 0.65 | ||
| Support 4 (S4) | 0.62 |
